SEC Form EFFECT filed by POINT Biopharma Global Inc.
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | December 29, 2023 |
Accession Number: | 0001193125-23-303590 | ||||||
Submission Type: | POS AM | ||||||
|